logo

For the Inventor, By the Inventor

Vigevano, Italy

Alberto Cerri

This inventor holds 5 USPTO granted patents. Top assignee: I.s.f. Societa Per Azioni. Active years: 1989-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Cerri. Retrieved from https://idiyas.com/inventor/alberto-cerri-18jka17f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Pavia, IT (1989 - 1992)
  • Vigevano Pavia, IT (1991 - 1993)

Company Filing History:

goldMedal5 out of 13 
 
I.s.f. Societa Per Azioni
 patents

Years Active: 1989-1993

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5200406 - Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines (1993-04-06),
2. 5130319 - Pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines (1992-07-14),
3. 5082939 - Pyridazine derivatives (1992-01-21),
4. 5053422 - Psychotropic perhydroazacycloalka [1,2-A] imidazole derivatives (1991-10-01),
5. 4873328 - Process for preparing alkoxyalkylidenehydrazinopyridazine derivatives (1989-10-10),

Title: The Innovative Contributions of Alberto Cerri

Introduction

Alberto Cerri is a notable inventor based in Vigevano Pavia, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that aid in cognitive functions. With a total of 5 patents, Cerri's work is recognized for its potential impact on memory restoration and learning enhancement.

Latest Patents

Cerri's latest patents include innovative imidazole derivatives that are designed to restore learning and treat memory difficulties. One of his notable inventions is a compound identified as 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole, which falls under the category of pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines. Additionally, he has developed pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines, which also aim to address cognitive challenges.

Career Highlights

Cerri is associated with I.S.F. Società Per Azioni, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to enhancing cognitive health through scientific research and development.

Collaborations

Throughout his career, Cerri has collaborated with esteemed colleagues such as Mario Pinza and Carlo Farina. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Alberto Cerri's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving cognitive health. His work continues to inspire advancements in the treatment of memory difficulties and learning challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…